(63) Continuation-in-part of application No. 10/409,694, 2.8 R 3. in et al.-w- allo et al. filed O
Apr. 8, 2003, now abandoned, which is a 6,586.403 B1 7/2003 Mathison et al. continuation …

Disclosed herein are methods for generating proteases with altered specificity for the target
molecules they cleave. The invention further discloses methods of using these proteases to …

(*) Notice: Subject to any disclaimer, the term of this 6,309,822 B1 10/2001 Fodor et al.
patent is extended or adjusted under 35 6,310,041 B1 10/2001 Haddox et al. USC 154 (b) …

4,427,660 A 1, 1984 Schiffman et al. 4,571,336 A 2f1986 Houcket al. 4,753,965 A 6, 1988
Stemericket al. 4,855.285 A 8, 1989 Stevens 4,977,244 A 12/1990 Much more et al …

Disclosed herein are methods for generating proteases with altered specificity for the target
molecules they cleave. The invention further discloses methods of using these proteases to …

4,330,466 A 5, 1982 Yanaihara et al. 4,427,660 A 1, 1984 Schiffman et al. 4,571,336 A
2f1986 Houcket al. 4,753,965 A 6, 1988 Stemericket al. 4,855.285 A 8, 1989 Stevens …

The invention provides use of a gene-regulatory peptide or functional analogue thereof for
the production of a pharmaceutical composition for the treatment of a disease involving an …

BACKGROUND 0003. In the aforementioned applications, small gene regulatory peptides
are described that are present naturally in pregnant women and are derived from proteolytic …

BACKGROUND 0003. In these earlier patent applications, small gene regulatory peptides
are described that are present naturally in pregnant women and are derived from proteolytic …

US7358330B2 - Immunoregulatory compositions - Google Patents US7358330B2 -
Immunoregulatory compositions - Google Patents Immunoregulatory compositions …